www.accessdata.fda.gov/.../022567Orig1s000SumR.pdf
M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES
PUBLIC HEALTH SERVICE
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH
DATE: January 18, 2011
FROM: Thomas P. Laughren, M.D.
Director, Division of Psychiatry Products
HFD-130
SUBJECT: Recommendation for approval action for vilazodone tablets as a treatment for
major depressive disorder (MDD).
TO: File NDA 22-567
